General Dynamics is a diversified defense and Gulfstream aerospace prime breaking to fresh all-time highs on a 48% year-over-year backlog surge to $131B Investing.com· apr 2026. Four straight EPS beats, a raised 2026 guide ($16.45–$16.55), an investment-grade balance sheet and a shrinking share count make this a clean quality-compounder setup — not a hype trade. The catch: it is ~4.4% extended above its 20-day EMA and a hair from its 52-week high, so we wait for a limit fill rather than chase. We grade this A, not A+ — the fundamentals and capital structure are pristine, but TP1 risk/reward sits right at the 1.5R floor and upside to the average analyst target (~$392) is a modest ~9%, so the trade math is good rather than exceptional.
General Dynamics is one of the world's largest defense contractors, operating across four segments: Aerospace (Gulfstream business jets), Marine Systems (Columbia- and Virginia-class submarines, surface combatants), Combat Systems (Abrams tanks, Stryker and wheeled vehicles, munitions) and Technologies (GDIT IT services + Mission Systems). Roughly two-thirds of revenue is tied to long-cycle US and allied government programs, giving the business a backlog-driven, recurring-revenue character that smooths economic cycles.
The Q1 2026 print captured the franchise at full stride: revenue of $13.5B (+10.3% YoY) with Marine Systems up 21% on submarine production and Aerospace delivering a record 38 first-quarter Gulfstream jets at a 15% margin GD IR· apr 2026. The structural moat — decades-long platform programs, deep government relationships and a $188B total estimated contract value — is exactly what makes GD a compounder rather than a cyclical trade.
| Metric | Value | Signal |
|---|---|---|
| Revenue (TTM) | $53.8B | +10% YoY |
| EBITDA (TTM) | $6.44B | Expanding |
| Operating Margin | 10.2% | Steady |
| Net Margin | 8.1% | Healthy |
| Net Income (TTM) | $4.34B | Growing |
| EPS (TTM) | $15.89 | 4 beats |
| ROE | 16.8% | Strong |
| Cash | $3.65B | Solid |
| Total Debt | $8.01B | D/E 0.31 |
| Trailing P/E | 22.7x | Reasonable |
| Fwd P/E | 21.4x | Fair for compounder |
| Analyst Target | $392 ($313–$444) | +9% upside |
GD scores well on growth, cash generation and quality (16.8% ROE), with valuation that sits in the "fair" — not cheap, not stretched — zone. At 21.4x forward earnings against a backlog up 48% and a raised guide, you are paying a market-style multiple for above-market visibility.
| Price | $360.22 |
| RSI (14) | 63.2 |
| EMA 20 | $345.08 |
| EMA 50 | $343.58 |
| EMA 200 | $337.39 |
| ATR (14) | $7.83 |
| 52W High | $369.70 |
Textbook bullish structure at fresh highs. The EMA stack is perfectly aligned — EMA20 ($345.08) > EMA50 ($343.58) > EMA200 ($337.39) — confirming a healthy intermediate uptrend, while price at $360.22 sits cleanly above all three. RSI at 63.2 is firmly bullish without being overbought (<70), leaving room to run. The one caveat is extension: price is ~4.4% above EMA20 and within ~2.6% of the 52-week high of $369.70 Yahoo Finance· live. With ATR at $7.83 (~2.2%), the cleaner entry is a small pullback toward the prior consolidation, not a breakout chase.
A diversified, investment-grade defense prime with a record backlog and no dilution overhang. The primary near-term risks are technical (extension/chasing) and policy (defense-budget headlines), not balance-sheet or franchise risk.
GD's downside is dominated by trade-timing (extension) and macro/policy headlines rather than anything structural. The balance sheet is investment-grade (D/E 0.31), there is no dilution machinery on EDGAR, beta is a defensive 0.34, and the $131B backlog hard-anchors forward revenue. That combination keeps the overall risk firmly in the moderate-low band SEC EDGAR· jun 2026.
This is a quality-compounder continuation trade, not a chase. GD is trending at fresh highs with a perfect EMA stack, four consecutive EPS beats, and a 2026 guide that management raised after Q1 to $16.45–$16.55 Seeking Alpha· apr 2026. The $131B backlog (+48% YoY) and 2:1 book-to-bill underwrite the forward earnings power that justifies the 21.4x multiple. We enter on a small limit pullback to $358.40 to avoid buying the extension, risking to $340.00 (below the EMA50 swing) for a clean 1.5R to $386.00 and a near-3R stretch toward the analyst-target zone at $412.50.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from Yahoo Finance, StockAnalysis.com, SEC EDGAR, company investor relations, and public market data as of 14 June 2026. Accuracy is not guaranteed.